If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020
2019

Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer

Pietrantonio, F., Lobefaro, R., Antista, M., Lonardi, S., Raimondi, A., Morano, F., Mosconi, S., Rimassa, L., Murgioni, S., Sartore-Bianchi, A., Tomasello, G., Longarini, R., Farina, G., Petrelli, F., Gori, S., Randon, G., Corallo, S., Pagani, F., Guarini, V., Palermo, F. & 11 others, Martinetti, A., Macagno, M., Barault, L., Perrone, F., Tamborini, E., Milione, M., Di Nicolantonio, F., Di Maio, M., Fucà, G., Di Bartolomeo, M. & de Braud, F., Nov 18 2019, In : Clin. Cancer Res..

Research output: Contribution to journalArticle

Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer

Pietrantonio, F., Lobefaro, R., Antista, M., Lonardi, S., Raimondi, A., Morano, F., Mosconi, S., Rimassa, L., Murgioni, S., Sartore-Bianchi, A., Tomasello, G., Longarini, R., Farina, G., Petrelli, F., Gori, S., Randon, G., Corallo, S., Pagani, F., Guarini, V., Palermo, F. & 11 others, Martinetti, A., Macagno, M., Barault, L., Perrone, F., Tamborini, E., Milione, M., Di Nicolantonio, F., Di Maio, M., Fucà, G., Di Bartolomeo, M. & de Braud, F., Nov 18 2019, In : Clin. Cancer Res.. p. 1-27 27 p.

Research output: Contribution to journalArticle

Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial

Vernieri, C., Signorelli, D., Galli, G., Ganzinelli, M., Moro, M., Fabbri, A., Tamborini, E., Marabese, M., Caiola, E., Broggini, M., Hollander, L., Gallucci, R., Vandoni, G., Gavazzi, C., Triulzi, T., Colombo, M. P., Rizzo, A. M., Corsetto, P. A., Pruneri, G., de Braud, F. & 3 others, Sozzi, G., Torri, V. & Garassino, M. C., May 2019, In : Clinical Lung Cancer. 20, 3, p. e413-e417

Research output: Contribution to journalArticle

Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?

Cavalieri, S., Platini, F., Bergamini, C., Resteghini, C., Galbiati, D., Bossi, P., Perrone, F., Tamborini, E., Quattrone, P., Licitra, L., Locati, L. D. & Alfieri, S., May 4 2019, In : Expert Opinion on Investigational Drugs. 28, 5, p. 435-443 9 p.

Research output: Contribution to journalArticle

Negative hyperselection of patients with RAS and BRAF wild-type metastatic colorectal cancer who received panitumumab-based maintenance therapy

Morano, F., Corallo, S., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Murialdo, R., Zaniboni, A., Sartore-Bianchi, A., Tomasello, G., Racca, P., Clavarezza, M., Adamo, V., Perrone, F., Gloghini, A., Tamborini, E., Busico, A., Martinetti, A., Palermo, F., Loupakis, F. & 5 others, Milione, M., Fucà, G., Di Bartolomeo, M., De Braud, F. & Pietrantonio, F., 2019, In : Journal of Clinical Oncology. 37, 33, p. 3099-3110 12 p.

Research output: Contribution to journalArticle

Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy

Morano, F., Corallo, S., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Murialdo, R., Zaniboni, A., Sartore-Bianchi, A., Tomasello, G., Racca, P., Clavarezza, M., Adamo, V., Perrone, F., Gloghini, A., Tamborini, E., Busico, A., Martinetti, A., Palermo, F., Loupakis, F. & 5 others, Milione, M., Fucà, G., Di Bartolomeo, M., de Braud, F. & Pietrantonio, F., Nov 20 2019, In : Journal of Clinical Oncology. 37, 33, p. 3099-3110 12 p.

Research output: Contribution to journalArticle

Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy

Morano, F., Corallo, S., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Murialdo, R., Zaniboni, A., Sartore-Bianchi, A., Tomasello, G., Racca, P., Clavarezza, M., Adamo, V., Perrone, F., Gloghini, A., Tamborini, E., Busico, A., Martinetti, A., Palermo, F., Loupakis, F. & 5 others, Milione, M., Fucà, G., Di Bartolomeo, M., de Braud, F. & Pietrantonio, F., Nov 20 2019, In : Journal of Clinical Oncology. 37, 33, p. 3099-3110 12 p.

Research output: Contribution to journalArticle

Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy

Morano, F., Corallo, S., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Murialdo, R., Zaniboni, A., Sartore-Bianchi, A., Tomasello, G., Racca, P., Clavarezza, M., Adamo, V., Perrone, F., Gloghini, A., Tamborini, E., Busico, A., Martinetti, A., Palermo, F., Loupakis, F. & 5 others, Milione, M., Fucà, G., Di Bartolomeo, M., de Braud, F. & Pietrantonio, F., Nov 20 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 33, p. 3099-3110 12 p.

Research output: Contribution to journalArticle

Open Access

Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract

Locati, L. D., Cavalieri, S., Bergamini, C., Resteghini, C., Alfieri, S., Calareso, G., Bossi, P., Perrone, F., Tamborini, E., Quattrone, P., Granata, R., Galbiati, D., Platini, F., Orlandi, E., Mariani, L. & Licitra, L., Oct 1 2019, In : Head and Neck. 41, 10, p. 3670-3676 7 p.

Research output: Contribution to journalArticle

Prognostic impact of ATM mutations in patients with metastatic colorectal cancer

Randon, G., Fucà, G., Rossini, D., Raimondi, A., Pagani, F., Perrone, F., Tamborini, E., Busico, A., Peverelli, G., Morano, F., Niger, M., Antista, M., Corallo, S., Saggio, S., Borelli, B., Zucchelli, G., Milione, M., Pruneri, G., Di Bartolomeo, M., Falcone, A. & 3 others, de Braud, F., Cremolini, C. & Pietrantonio, F., Dec 1 2019, In : Scientific Reports. 9, 1, 2858.

Research output: Contribution to journalArticle

Open Access
2018

Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury

Magnaghi, P., Salom, B., Cozzi, L., Amboldi, N., Ballinari, D., Tamborini, E., Gasparri, F., Montagnoli, A., Raddrizzani, L., Somaschini, A., Bosotti, R., Orrenius, C., Bozzi, F., Pilotti, S., Galvani, A., Sommer, J., Stacchiotti, S. & Isacchi, A., Mar 2018, In : Molecular Cancer Therapeutics. 17, 3, p. 603-613 11 p.

Research output: Contribution to journalArticle

Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study

Pietrantonio, F., Fucà, G., Morano, F., Gloghini, A., Corso, S., Aprile, G., Perrone, F., De Vita, F., Tamborini, E., Tomasello, G., Gualeni, A. V., Ongaro, E., Busico, A., Giommoni, E., Volpi, C. C., Laterza, M. M., Corallo, S., Prisciandaro, M., Antista, M., Pellegrinelli, A. & 7 others, Castagnoli, L., Pupa, S. M., Pruneri, G., de Braud, F., Giordano, S., Cremolini, C. & Di Bartolomeo, M., Mar 1 2018, In : Clinical Cancer Research. 24, 5, p. 1082-1089 8 p.

Research output: Contribution to journalArticle

Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study

Stacchiotti, S., Morosi, C., Lo Vullo, S., Casale, A., Palassini, E., Frezza, A. M., Dinoi, G., Messina, A., Gronchi, A., Cavalleri, A., Venturelli, E., Morelli, D., Pilotti, S., Collini, P., Brich, S., Tamborini, E., Mariani, L. & Casali, P. G., Oct 15 2018, In : Cancer. 124, 20, p. 4056-4063 8 p.

Research output: Contribution to journalArticle

Self-Assembled Nanomicelles as Curcumin Drug Delivery Vehicles: Impact on Solitary Fibrous Tumor Cell Protein Expression and Viability

Dagrada, G., Rupel, K., Zacchigna, S., Tamborini, E., Pilotti, S., Cavalleri, A., Fechner, L. E., Laurini, E., Smith, D. K., Brich, S. & Pricl, S., Oct 1 2018, In : Molecular Pharmaceutics. 15, 10, p. 4689-4701 13 p.

Research output: Contribution to journalArticle

2017

Best practices for the management of local-regional recurrent chordoma: A position paper by the Chordoma Global Consensus Group

Stacchiotti, S., Gronchi, A., Fossati, P., Akiyama, T., Alapetite, C., Baumann, M., Blay, J. Y., Bolle, S., Boriani, S., Bruzzi, P., Capanna, R., Caraceni, A., Casadei, R., Colia, V., Debus, J., Delaney, T., Desai, A., Dileo, P., Dijkstra, S., Doglietto, F. & 30 others, Flanagan, A., Froelich, S., Gardner, P. A., Gelderblom, H., Gokaslan, Z. L., Haas, R., Heery, C., Hindi, N., Hohenberger, P., Hornicek, F., Imai, R., Jeys, L., Jones, R. L., Kasper, B., Kawai, A., Krengli, M., Leithner, A., Logowska, I., Martin Broto, J., Mazzatenta, D., Morosi, C., Nicolai, P., Norum, O. J., Picci, P., Radaelli, S., Ricchini, F., Tamborini, E., Torri, V., Vanel, D. & Casali, P. G., 2017, In : Annals of Oncology. 28, 6, p. 1230-1242 13 p.

Research output: Contribution to journalArticle

Best practices for the Management of Local-regional Recurrent Chordoma. A Position Paper by the Chordoma Global Consensus Group

Stacchiotti, S., Gronchi, A., Fossati, P., Akiyama, T., Alapetite, C., Baumann, M., Blay, J. Y., Bolle, S., Boriani, S., Bruzzi, P., Capanna, R., Caraceni, A., Casadei, R., Colia, V., Debus, J., Delaney, T. F., Desai, A., Dileo, P., Dijkstra, S. D., Doglietto, F. & 45 others, Flanagan, A. M., Froelich, S., Gardner, P. A., Gelderblom, H., Gokaslan, Z. L., Haas, R., Heery, C., Hindi, N., Hohenberger, P., Hornicek, F. J., Imai, R., Jeys, L., Jones, R. L., Kasper, B., Kawai, A., Krengli, M., Leithner, A., Logowska, I., Martin-Broto, J., Mazzatenta, D., Morosi, C., Nicolai, P., Norum, O. J., Patel, S., Penel, N., Picci, P., Pilotti, S., Radaelli, S., Ricchini, F., Rutkowski, P., Scheipl, S., Sen, C., Tamborini, E., Thornton, K. A., Timmermann, B., Torri, V., Tunn, P. U., Uhl, M., Yamada, Y., Weber, D. C., Vanel, D., Varga, P. P., Vleggeert-Lankamp, C., Casali, P. G. & Sommer, J., Feb 9 2017, In : Annals of Oncology. 28, 6, p. 1230-1242 13 p.

Research output: Contribution to journalArticle

Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study.

Pietrantonio, F., Fuca, G., Morano, F., Gloghini, A., Corso, S., Aprile, G., Perrone, F., De Vita, F., Tamborini, E., Tomasello, G., Gualeni, A. V., Ongaro, E., Busico, A., Giommoni, E., Volpi, C. C., Laterza, M. M., Corallo, S., Prisciandaro, M., Antista, M., Pellegrinelli, A. & 7 others, Castagnoli, L., Pupa, S. M., Pruneri, G., de Braud, F., Giordano, S., Cremolini, C. & Di Bartolomeo, M., Dec 1 2017, In : Clinical Cancer Research.

Research output: Contribution to journalArticle

Establishment and genomic characterization of the new chordoma cell line Chor-IN-1

Bosotti, R., Magnaghi, P., Di Bella, S., Cozzi, L., Cusi, C., Bozzi, F., Beltrami, N., Carapezza, G., Ballinari, D., Amboldi, N., Lupi, R., Somaschini, A., Raddrizzani, L., Salom, B., Galvani, A., Stacchiotti, S., Tamborini, E. & Isacchi, A., Dec 1 2017, In : Scientific Reports. 7, 1, 9226.

Research output: Contribution to journalArticle

FNA and CNB in the diagnosis of pulmonary lesions: A single-center experience on 665 patients, comparison between two periods

Marchianò, A. V., Cosentino, M., Di Tolla, G., Greco, F. G., Silva, M., Sverzellati, N., Fabbri, A., Tamborini, E., Lo Russo, G., Mariani, L., Lalli, L. & Pastorino, U., Jul 1 2017, In : Tumori. 103, 4, p. 360-366 7 p.

Research output: Contribution to journalArticle

Heterogeneity of acquired resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer

Pietrantonio, F., Vernieri, C., Siravegna, G., Mennitto, A., Berenato, R., Perrone, F., Gloghini, A., Tamborini, E., Lonardi, S., Morano, F., Picciani, B., Busico, A., Volpi, C. C., Martinetti, A., Battaglin, F., Bossi, I., Pellegrinelli, A., Milione, M., Cremolini, C., Di Bartolomeo, M. & 2 others, Bardelli, A. & De Braud, F., May 15 2017, In : Clinical Cancer Research. 23, 10, p. 2414-2422 9 p.

Research output: Contribution to journalArticle

Heterogeneity of acquired resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer

Pietrantonio, F., Vernieri, C., Siravegna, G., Mennitto, A., Berenato, R., Perrone, F., Gloghini, A., Tamborini, E., Lonardi, S., Morano, F., Picciani, B., Busico, A., Volpi, C. C., Martinetti, A., Battaglin, F., Bossi, I., Pellegrinelli, A., Milione, M., Cremolini, C., Di Bartolomeo, M. & 2 others, Bardelli, A. & De Braud, F., May 15 2017, In : Clinical Cancer Research. 23, 10, p. 2414-2422 9 p.

Research output: Contribution to journalArticle

Immunohistochemical and molecular profile of salivary gland cancer in children

Locati, L. D., Collini, P., Imbimbo, M., Barisella, M., Testi, A., Licitra, L. F., Löning, T., Tiemann, K., Quattrone, P., Bimbatti, E., Chiaravalli, S., Casanova, M., Tamborini, E., Carta, R., Gasparini, P., Guzzo, M., Massimino, M. & Ferrari, A., Sep 1 2017, In : Pediatric Blood and Cancer. 64, 9, e26468.

Research output: Contribution to journalArticle

Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study

Cremolini, C., Morano, F., Moretto, R., Berenato, R., Tamborini, E., Perrone, F., Rossini, D., Gloghini, A., Busico, A., Zucchelli, G., Baratelli, C., Tamburini, E., Tampellini, M., Sensi, E., Fucà, G., Volpi, C., Milione, M., Di Maio, M., Fontanini, G., De Braud, F. & 2 others, Falcone, A. & Pietrantonio, F., Dec 1 2017, In : Annals of oncology : official journal of the European Society for Medical Oncology. 28, 12, p. 3009-3014 6 p.

Research output: Contribution to journalArticle

Quadruple-negative GIST is a sentinel for unrecognized neurofibromatosis type 1 syndrome

Gasparotto, D., Rossi, S., Polano, M., Tamborini, E., Lorenzetto, E., Sbaraglia, M., Mondello, A., Massani, M., Lamon, S., Bracci, R., Mandolesi, A., Frate, E., Stanzial, F., Agaj, J., Mazzoleni, G., Pilotti, S., Gronchi, A., Dei Tos, A. P. & Maestro, R., 2017, In : Clinical Cancer Research. 23, 1, p. 273-282 10 p.

Research output: Contribution to journalArticle

Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome.

Gasparotto, D., Rossi, S., Polano, M., Tamborini, E., Lorenzetto, E., Sbaraglia, M., Mondello, A., Massani, M., Lamon, S., Bracci, R., Mandolesi, A., Frate, E., Stanzial, F., Agaj, J., Mazzoleni, G., Pilotti, S., Gronchi, A., Dei Tos, A. P. & Maestro, R., Jan 1 2017, In : Clinical Cancer Research. 23, 1, p. 273-282 10 p.

Research output: Contribution to journalArticle

Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors

Pusceddu, S., Prinzi, N., Lo Russo, G., Femia, D., Milione, M., Perrone, F., Tamborini, E., Concas, L., Pulice, I., Vernieri, C., Corti, F., Buzzoni, R. & De Braud, F., 2017, In : Future Oncology. 13, 19, p. 1677-1683 7 p.

Research output: Contribution to journalArticle

Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift

Fabbri, A., Cossa, M., Sonzogni, A., Bidoli, P., Canova, S., Cortinovis, D., Abbate, M. I., Calabrese, F., Nannini, N., Lunardi, F., Rossi, G., La Rosa, S., Capella, C., Tamborini, E., Perrone, F., Busico, A., Capone, I., Valeri, B., Pastorino, U., Albini, A. & 1 others, Pelosi, G., Jul 1 2017, In : Virchows Archiv. 471, 1, p. 31-47 17 p.

Research output: Contribution to journalArticle

Uncommon somatic mutations in metastatic NUT midline carcinoma

Cavalieri, S., Stathis, A., Fabbri, A., Sonzogni, A., Perrone, F., Tamborini, E., Pelosi, G., de Braud, F. & Platania, M., Nov 1 2017, In : Tumori. 103, p. S5-S8

Research output: Contribution to journalArticle

2016

Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer

Pietrantonio, F., de Braud, F., Milione, M., Maggi, C. A., Iacovelli, R., Dotti, K. F., Perrone, F., Tamborini, E., Caporale, M., Berenato, R., Leone, G., Pellegrinelli, A., Bossi, I., Festinese, F., Federici, S. & Di Bartolomeo, M., 2016, In : Targeted Oncology. 11, 3, p. 337-343 7 p.

Research output: Contribution to journalArticle

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: A clinical and translational study

Pietrantonio, F., Berenato, R., Maggi, C., Caporale, M., Milione, M., Perrone, F., Tamborini, E., Baratti, D., Kusamura, S., Mariani, L., Niger, M., Mennitto, A., Gloghini, A., Bossi, I., Settanni, G., Busico, A., Bagnoli, P. F., Di Bartolomeo, M., Deraco, M. & de Braud, F., May 6 2016, In : Journal of Translational Medicine. 14, 1, 125.

Research output: Contribution to journalArticle

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: A clinical and translational study

Pietrantonio, F., Berenato, R., Maggi, C. A., Caporale, M., Milione, M., Perrone, F., Tamborini, E., Baratti, D., Kusamura, S., Mariani, L., Niger, M., Mennitto, A., Gloghini, A., Bossi, I., Settanni, G., Busico, A., Bagnoli, P. F., Di Bartolomeo, M., Deraco, M. & de Braud, F., 2016, In : Journal of Translational Medicine. 14, 1

Research output: Contribution to journalArticle

Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer

Pietrantonio, F., Vernieri, C., Siravegna, G., Mennitto, A., Berenato, R., Perrone, F., Gloghini, A., Tamborini, E., Lonardi, S., Morano, F., Picciani, B., Busico, A., Volpi, C. C., Martinetti, A., Battaglin, F., Bossi, I., Pellegrinelli, A., Milione, M., Cremolini, C., Di Bartolomeo, M. & 2 others, Bardelli, A. & de Braud, F., Oct 25 2016, In : Clinical Cancer Research.

Research output: Contribution to journalArticle

Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer

Pietrantonio, F., Vernieri, C., Siravegna, G., Mennitto, A., Berenato, R., Perrone, F., Gloghini, A., Tamborini, E., Lonardi, S., Morano, F., Picciani, B., Busico, A., Volpi, C. C., Martinetti, A., Battaglin, F., Bossi, I., Pellegrinelli, A., Milione, M., Cremolini, C., Di Bartolomeo, M. & 2 others, Bardelli, A. & De Braud, F., 2016, In : Clinical Cancer Research.

Research output: Contribution to journalArticle

Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer.

Pietrantonio, F., Vernieri, C., Siravegna, G., Mennitto, A., Berenato, R., Perrone, F., Gloghini, A., Tamborini, E., Lonardi, S., Morano, F., Picciani, B., Busico, A., Volpi, C. C., Martinetti, A., Battaglin, F., Bossi, I., Pellegrinelli, A., Milione, M., Cremolini, C., Di Bartolomeo, M. & 2 others, Bardelli, A. & de Braud, F., Oct 1 2016, In : Clinical Cancer Research.

Research output: Contribution to journalArticle

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b

Vergani, E., Di Guardo, L., Dugo, M., Rigoletto, S., Tragni, G., Ruggeri, R., Perrone, F., Tamborini, E., Gloghini, A., Arienti, F., Vergani, B., Deho, P., De Cecco, L., Vallacchi, V., Frati, P., Shahaj, E., Villa, A., Santinami, M., De Braud, F., Rivoltini, L. & 1 others, Rodolfo, M., 2016, In : Oncotarget. 7, 4, p. 4428-4441 14 p.

Research output: Contribution to journalArticle

Synergistic activation upon MET and ALK coamplification sustains targeted therapy in sarcomatoid Carcinoma, a deadly subtype of lung cancer

Pelosi, G., Gasparini, P., Conte, D., Fabbri, A., Perrone, F., Tamborini, E., Pupa, S. M., Ciravolo, V., Caserini, R., Rossi, G., Cavazza, A., Papotti, M., Nakatani, Y., Maisonneuve, P., Pastorino, U. & Sozzi, G., 2016, In : Journal of Thoracic Oncology. 11, 5, p. 718-728 11 p.

Research output: Contribution to journalArticle

Synergistic activation upon MET and ALK coamplification sustains targeted therapy in sarcomatoid Carcinoma, a deadly subtype of lung cancer

Pelosi, G., Gasparini, P., Conte, D., Fabbri, A., Perrone, F., Tamborini, E., Pupa, S., Ciravolo, V., Caserini, R., Rossi, G., Cavazza, A., Papotti, M., Nakatani, Y., Maisonneuve, P., Pastorino, U. & Sozzi, G., 2016, In : Journal of Thoracic Oncology. 11, 5, p. 718-728 11 p.

Research output: Contribution to journalArticle

Synergistic activation upon MET and ALK coamplification sustains targeted therapy in sarcomatoid Carcinoma, a deadly subtype of lung cancer

Pelosi, G., Gasparini, P., Conte, D., Fabbri, A., Perrone, F., Tamborini, E., Pupa, S., Ciravolo, V., Caserini, R., Rossi, G., Cavazza, A., Papotti, M., Nakatani, Y., Maisonneuve, P., Pastorino, U. & Sozzi, G., 2016, In : Journal of Thoracic Oncology. 11, 5, p. 718-728 11 p.

Research output: Contribution to journalArticle

Toward the molecular dissection of peritoneal pseudomyxoma

Pietrantonio, F., Perrone, F., Mennitto, A., Gleeson, E. M., Milione, M., Tamborini, E., Busico, A., Settanni, G., Berenato, R., Caporale, M., Morano, F., Bossi, I., Pellegrinelli, A., Di Bartolomeo, M., de Braud, F., Baratti, D., Bowne, W. B., Kusamura, S. & Deraco, M., Nov 2016, In : Annals of Oncology. 27, 11, p. 2097-2103 7 p.

Research output: Contribution to journalArticle

2015

BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis

Cremolini, C., Di Bartolomeo, M., Amatu, A., Antoniotti, C., Moretto, R., Berenato, R., Perrone, F., Tamborini, E., Aprile, G., Lonardi, S., Sartore-Bianchi, A., Fontanini, G., Milione, M., Lauricella, C., Siena, S., Falcone, A., De Braud, F., Loupakis, F. & Pietrantonio, F., Oct 1 2015, In : Annals of Oncology. 26, 10, p. 2092-2097 6 p., mdv290.

Research output: Contribution to journalArticle

Different clinical effects upon separate inhibition of coexisting EGFR and PI3KCA mutations in a lung adenocarcinoma patient

Tiseo, M., Bersanelli, M., Perrone, F., Tamborini, E., Settanni, G., Busico, A., Rossi, G., Ardizzoni, A. & Pelosi, G., 2015, In : Lung Cancer. 87, 2, p. 204-206 3 p.

Research output: Contribution to journalArticle

Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer

Pietrantonio, F., de Braud, F., Milione, M., Maggi, C., Iacovelli, R., Dotti, K. F., Perrone, F., Tamborini, E., Caporale, M., Berenato, R., Leone, G., Pellegrinelli, A., Bossi, I., Festinese, F., Federici, S. & Di Bartolomeo, M., Nov 4 2015, (Accepted/In press) In : Targeted Oncology.

Research output: Contribution to journalArticle